Cargando…
IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Scientific Publishers
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164599/ http://dx.doi.org/10.1016/j.diabres.2022.109320 |
| _version_ | 1784720171765596160 |
|---|---|
| author | Verma, R. Ranadive, R. Kalra, S. Lathia, T. Saraf, A. Thakur, S. Sarwate, A. Lakhani, O. Das, R. Shenoy, M.T. Joshi, S. Singal, A. |
| author_facet | Verma, R. Ranadive, R. Kalra, S. Lathia, T. Saraf, A. Thakur, S. Sarwate, A. Lakhani, O. Das, R. Shenoy, M.T. Joshi, S. Singal, A. |
| author_sort | Verma, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9164599 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Scientific Publishers |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91645992022-06-04 IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India Verma, R. Ranadive, R. Kalra, S. Lathia, T. Saraf, A. Thakur, S. Sarwate, A. Lakhani, O. Das, R. Shenoy, M.T. Joshi, S. Singal, A. Diabetes Res Clin Pract Article Elsevier Scientific Publishers 2022-04 2022-06-03 /pmc/articles/PMC9164599/ http://dx.doi.org/10.1016/j.diabres.2022.109320 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Verma, R. Ranadive, R. Kalra, S. Lathia, T. Saraf, A. Thakur, S. Sarwate, A. Lakhani, O. Das, R. Shenoy, M.T. Joshi, S. Singal, A. IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India |
| title | IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India |
| title_full | IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India |
| title_fullStr | IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India |
| title_full_unstemmed | IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India |
| title_short | IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India |
| title_sort | idf21-0186 real-world effectiveness of diabefly digital therapeutics program for glycemic control during covid-19 pandemic in india |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164599/ http://dx.doi.org/10.1016/j.diabres.2022.109320 |
| work_keys_str_mv | AT vermar idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT ranadiver idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT kalras idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT lathiat idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT sarafa idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT thakurs idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT sarwatea idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT lakhanio idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT dasr idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT shenoymt idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT joshis idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia AT singala idf210186realworldeffectivenessofdiabeflydigitaltherapeuticsprogramforglycemiccontrolduringcovid19pandemicinindia |